CNS Metastases Withdrawn Phase Trials for Irinotecan (DB00762)

Also known as: Metastases, CNS / Metastases to central nervous system / Central Nervous System (CNS) Metastases / Central Nervous System Metastases / Metastases of Central Nervous System / Metastatic malignant neoplasm to central nervous system (disorder) / CNS metastases (tumor staging)

IndicationStatusPhase
DBCOND0050898 (CNS Metastases)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01939483A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesTreatment